Connect with us


Good Stocks To Buy Right Now? 4 Cyclical Stocks For Your Watchlist

Could cyclical stocks be a viable play as inflation continues to heat up?
The post Good Stocks To Buy Right Now? 4 Cyclical Stocks For Your Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information |



4 Cyclical Stocks That Investors May Be Shifting Their Attention Towards Right Now

In the stock market today, inflation has constantly been on the minds of many investors. With the consumer price index rising 7% over the past year at the highest rate since 1982, there have been concerns of faster Fed rate hikes on stocks. The good news is that rising inflation does not necessarily spell the end of a bullish market. Inflation can be a headwind for the broader market, but it can also be a tailwind for some cyclical stocks

Despite the Omicron variant continuing to spread like wildfire across the U.S, there are reasons to remain optimistic. For the most part, this could be thanks to recent comments from White House Chief Medical Advisor Dr Anthony Fauci. According to Fauci, the U.S. is approaching the ‘threshold’ of transitioning to living with the coronavirus as a manageable disease. Overall, while the Omicron variant is more transmissible, it often brings with it less severe symptoms. Hence, with the world learning to live with the virus, cyclical stocks could be appealing to some investors again.

For instance, Dish Network (NASDAQ: DISH) is in renewed talks to merge with DirecTV. Namely, a discussion between the two satellite-TV operators is being pushed by private equity firm TPG Capital. The likes of which bought a 30% stake in DirecTV from AT&T (NYSE: T) last year. Should this merger deal follow through, it would create a pay-TV operator with more than 20 million subscribers. If you think cyclicals are poised to shine this year, do you have this list of top cyclical stocks to watch in the stock market right now?

Top Cyclical Stocks To Watch Right Now


First up, we have Redfin, a tech-powered real estate company. In essence, the company is an online service that makes listing and shopping for a home easier. The company is one of the biggest players in the real estate space, with a presence in over 90 markets in the U.S and Canada. On top of that, the company sells and buys more than 235,000 a year. Over the past year, the real estate market has not been doing too well due to the pandemic. However, as the economy is recovering, could this be the best time to buy the dip?

Yesterday, Redfin announced that they will be acquiring Bay Equity Home Loans (BEHL), a national, full-service mortgage lender. Redfin will pay an estimate of $135 million in cash and stock to acquire the company. BEHL is a licensed mortgage lender in 42 states and employs approximately 1,200 people. For the most part, this is a strategic move on Redfin’s part to become a one-stop-shop for brokerage, lending, and other services. In theory, this should boost Redfin’s lending business. Redfin expects the acquisition to close in the second quarter of 2022. On that note, would you be keeping an eye on RDFN stock? 

RDFN stock
Source: TD Ameritrade TOS

[Read More] Stock Market Today: Dow Jones, S&P 500 Up After Powell Comments; Didi Gains On Potential Hong Kong IPO

Shake Shack

Next up is the burger joint Shake Shack. In short, the company operates roadside burger stands and serves burgers, hot dogs, fries, and milkshakes to name a few. The company operates over 300 Shacks, of which over 200 are domestic, company-operated Shacks. Besides that, it also has over 116 international licensed Shacks. Yesterday, SHAK stock increased by over 13% in response to the following news.

The company announced their preliminary unaudited results for the Q4 of 2021. Shake Shack reported a total revenue of over $203 million, a year-over-year increase of 29%. On an annual scale, it sees a total revenue of over $739 million, amounting to a 41.5% year-over-year increase. Furthermore, Shack sales continued to recover with Q4 same-shack sales growth of 20.8% compared to 2020. At the same time, the company also plans to open up 75 more restaurants globally in 2022, which includes adding 10 locations to its fledgling drive-thru footprint. As the company continues to expand, would you be buying SHAK stock?

SHAK stock chart
Source: TD Ameritrade TOS is a leading Chinese e-commerce company often compared to the likes of e-commerce giant Alibaba Group (NYSE: BABA). operates as one of the largest e-commerce platforms in the Chinese market. The Beijing-based firm caters to over 550 million annual active customers with direct access to a vast range of high-quality products. On top of that, its cross-border platform also allows brands from around the world to sell directly to Chinese consumers, even if they do not have any physical presence in China. Since the start of the year, JD stock has increased by over 10%.

Earlier this week, opened two retail stores in the Netherlands that will be manned by robots preparing and delivering packages. The “robotic shops”, branded Ochama, marks the company’s first venture into Europe with brick-and-mortar locations. Ultimately, this highlights the e-commerce giant’s ambition to expand beyond China. According to, shoppers can use the Ochama app to order products ranging from food to home furnishings. Subsequently, shoppers would then go to the store to collect their orders which would be delivered to them by robots through a conveyor belt. With looking to branch out into international markets, does JD stock deserve a spot on your watchlist?

JD stock chart
Source: TD Ameritrade TOS

[Read More] Top Stocks To Buy Now? 4 Cruise Line Stocks Making Headlines

Sinclair Broadcast Group 

Finishing up our list is the Sinclair Broadcast Group, a diversified media company and provider of local sports and news. The company owns or operates 294 television stations across the U.S in 89 markets. To be precise, it primarily operates in the broadcast and local sports segments. Also, the stations are affiliates of various television networks, including ABC, CBS, NBC, and Fox. Over the past month. SBGI stock has increased by more than 10%.

According to a Bloomberg report last week, Sinclair is close to securing deals to air NBA games on its new streaming service. Additionally, there would be $600 million of financing to support this expansion. If the deal takes place, Sinclair’s sports network unit, Diamond Sports group, would receive the regional digital rights to the NBA, adding to the broadcast rights Sinclair already owns. Moreover, this funding would also help Diamond to develop the new streaming app in the first half of this year. Given this news, would you be watching SBGI stock?

SBGI stock
Source: TD Ameritrade TOS

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!

The post Good Stocks To Buy Right Now? 4 Cyclical Stocks For Your Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information |

Read More

Continue Reading

Spread & Containment

A dog has caught monkeypox from one of its owners, highlighting risk of the virus infecting pets and wild animals

The monkeypox virus can easily spread between humans and animals. A veterinary virologist explains how the virus could go from people to wild animals in…



A dog in Paris has become the first case of a pet contracting monkeypox from its owners. Cavan Images via Getty Images

A dog in Paris has caught monkeypox from one of its owners, both of whom were infected with the virus, according to a scientific paper published on Aug. 10, 2022. This is the first case of a dog contracting the monkeypox virus through direct contact with skin lesions on a human.

I am a veterinary pathologist and virologist who has been working with poxviruses for over 20 years. I study how these viruses evade the immune system and am working on modifying poxviruses to prevent infection as well as treat other diseases, including cancer.

With monkeypox spreading in humans throughout the world, my colleagues and I have begun to worry about the increased risk of monkeypox spreading from humans to animals. If monkeypox spreads to wildlife species in the U.S. and Europe, the virus could become endemic in these places – where it has historically been absent – resulting in more frequent outbreaks. The report of the infected dog shows that there is a decent chance these fears could become a reality.

A microscope image of a bunch blue circles in a brown-colored cell.
The monkeypox virus – the blue circles in this image of an infected cell – is a poxvirus similar to smallpox and cowpox and can easily infect many different species. NIAID/Wikimedia Commons, CC BY

A species-jumping virus

Monkeypox is a poxvirus in the same family as variola – the virus that causes smallpox – and cowpox viruses and likely evolved in animals before jumping to humans. Monkeypox causes painful lesions in both humans and animals and, in rare cases, can be deadly. Researchers have found the monkeypox virus in several species of wild rodents, squirrels and primates in Africa, where the virus is endemic. Monkeypox does not need to mutate or evolve at all to be able to infect many different species. It can easily spread from animals to people and back again.

Though there is a fair bit of research on monkeypox, a lot more work has been done on cowpox, a similar zoonotic poxvirus that is endemic in Europe. Over the years, there have been several reports of cowpox infection spreading from animals to humans in Europe.

From people to animals

Until recently, most monkeypox infections occurred in specific areas of Africa where some wildlife species act as reservoirs for the virus. These outbreaks are usually contained quickly through isolation of infected individuals and vaccinating people around the infected individual. The current situation is very different though.

With nearly 40,000 cases globally as of Aug. 17, 2022 – and more than 12,500 cases in the U.S. alone – monkeypox is now widespread within the human population. The risk of any one person transmitting the virus to an animal – particularly a wild one – is small, but the more people are infected, the greater the chances. It’s a numbers game.

There are a number of ways viruses can transfer from animals to people – called spillover – and from people back to animals – called spillback. Since monkeypox is most easily spread through direct skin-to-skin contact, it is a bit more difficult to transmit between species than COVID-19, but certainly possible.

The case of the dog in Paris provides a clear example of how cuddling or being close to a pet can spread the virus. Previous studies on poxviruses like monkeypox have shown that they can stay active in fecal matter. This means that there is a risk of wild animals, likely rodents, catching it from human waste.

A grey rat.
There are a number of species that host monkeypox in Africa – like this gambian rat. Monkeypox can spread from humans to many other animals, including dogs and likely cats and other species of rodents. Louisvarley/Wikimedia Commons, CC BY-SA

The monkeypox virus is also present in saliva. While more research needs to be done, it is potentially possible that an infected person could discard food that would then be eaten by a rodent.

The chances of any one of these events happening is extremely low. But I and other virologists worry that with more people becoming infected, there is a greater risk that rodents or other animals will come into contact with urine, feces or saliva that is contaminated with the virus.

Finally, there is the risk of people giving monkeypox to a pet, which then passes it on to other animals. One case study in Germany described an outbreak of cowpox that was caused when someone took an infected cat to a veterinary clinic and four other cats were subsequently infected. It is feasible that an infected household pet could spread the virus to wild animals somehow.

How to help

One of the key reasons that the World Health Organization was able to eradicate smallpox is that it only infects people, so there were no animal reservoirs that could re-introduce the virus to human populations.

Monkeypox is zoonotic and already has several animal reservoirs, though these are currently limited to Africa. But if monkeypox escapes into wild animal populations in the U.S., Europe or other locations, there will be always be potential for animals to spread it back to humans. With this in mind, there are a number of things people can do to reduce the risks with regard to animals.

As with any infectious disease, be informed about the signs and symptoms of monkeypox and how it is transmitted. If you suspect you have the virus, contact a doctor and isolate from other people.

As a veterinarian, I strongly encourage anyone with monkeypox to protect your pets. The case in Paris shows that dogs can get infected from contact with their owners, and it is likely that many other species, including cats, are susceptible, too. If you have monkeypox, try to have other people take care of your animals for as long as lesions are present. And if you think your pet has a monkeypox infection, be sure to contact a veterinarian so they can test the lesion and provide care when needed.

Even though monkeypox has been declared a public health emergency, it is unlikely to directly affect most people. Taking precautionary steps can protect you and your pets and will hopefully prevent monkeypox from getting into wildlife in the U.S., too.

Amy Macneill does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading


A-levels: A grades are up compared to pre-pandemic results

The pandemic has has a serious impact on school pupils – but a record number have applied to university.



Fewer students are getting their first choice of university than in 2021. Monkey Business Images/Shutterstock

The 2022 A-level results are in, and the number of students receiving A or A* grades has fallen – down by 8.4% on 2021.

For the first time since 2019, A-level results are being decided by formal exams. Students were warned that grades were likely to be lower than in 2020 and 2021, when cancelled exams and teacher assessments in A-levels led to record high results. Nevertheless, the proportion of students receiving A grades is up from pre-pandemic levels in 2019.

A busy end to the admissions round is under way for universities and students, and the next steps for students still living with the impact of the pandemic are becoming clearer.

In 2021, some universities were over subscribed and had to offer significant incentives for students to defer their places. While the number of students in 2022 accepted on a UK university course – 425,830 – is higher than in 2019 and the second highest on record, it is 2% lower than in 2021. Just a few days before the results were out, thousands of students did not yet hold an offer of an university place.

Over the past two years, students studying qualifications, whether BTEC, T-level or A-level, have had to cope with the consequences of the pandemic for a significant proportion of their course. This has included school closures and remote lessons, social isolation, illness and increased levels of mental stress.

Highest number of applications

Nevertheless, 2022 has seen the highest ever numbers of applications to higher education, with 44% of 18 year olds applying. This number includes record numbers of students from areas of the country with historically low participation in higher education. It demonstrates that many young people believe higher education can make a difference to their future opportunities.

For the lucky ones who get the grades to gain a place at their first choice of university, planning for their degree course starts right away. A record number of Scottish students have already been accepted to their first choice of university.

The best advice for those students who don’t receive confirmation that they have been accepted by their first choice university is to ring the university, who will have staff on hand to explore their options.

For students who haven’t got a university place, it is still possible to explore options though clearing – which allows students without offers to find places on university courses that haven’t been fully subscribed. Students in this position should try to keep calm, write down their options and avoid quick decisions.

For those young people who do go to university, there will be challenges. With the cost of living for all rising rapidly, people on a lower income – as many students are – will feel the pinch of higher bills for food or rent.

Support from universities

The pandemic saw a serious and concerning rise in mental health issues affecting young people. Universities need to be ready to give holistic support to students as they transition into university and settle into undergraduate life. This means support for academic transition needs to be delivered in the context of good available support for mental health and wellbeing.

However, Universities UK, an advocacy groups for universities, has recently pointed out the wide range of benefits for those who study for a degree, including the £9,500 more per year on average graduates in England earn compared with non-graduates. It also draws attention to the value of degrees to improve the life chances of young people, to build skills and to contribute to society.

For many young people, getting a degree gives them access to a vocation such as teaching or working as a health professional. For others it is a path to travel and adventure. For many, the university journey is a place where young people find their tribe and begin to understand their identity.

For the class of 22, making it to university might mean life-changing opportunities. Given the challenges and restrictions of the last few years, this has never been more important.

Helena Gillespie receives funding from the European Union.

Read More

Continue Reading


Pfizer Inc (NYSE: PFE) To Acquire Global Blood Therapeutics For $5 Billion

According to sources familiar with the matter, the Wall Street Journal reported that Pfizer Inc (NYSE: PFE) was in advanced discussions to acquire pharmaceutical…



According to sources familiar with the matter, the Wall Street Journal reported that Pfizer Inc (NYSE: PFE) was in advanced discussions to acquire pharmaceutical company Global Blood Therapeutics (NASDAQ: GBT) for $5 billion.

Pfizer, too, acquired Global Blood Therapeutics 

Pfizer wants to close a deal soon, but there are still other interested parties, according to the article.

Global Blood Therapeutics, which manufactures Oxbryta, the blood disorder medication, saw its shares jump 44%  on Friday afternoon to a two-year high. As of Thursday’s closing, the company’s market cap was $3.12 billion.

A spokesman for Global Blood stated the company does not “comment on market rumors or speculation,” while Pfizer declined to respond on the matter.

With plenty of cash left over after selling its COVID-19 vaccine, New York-based Pfizer is searching for deals that may generate billions of dollars annual sales by 2030.

Its $11.6 billion acquisition of migraine medication manufacturer Biohaven Pharmaceutical Holding (NASDAQ: BHVN) in May was the most recent in a series of purchases that also included Trillium Therapeutics and Arena Pharmaceuticals in recent years.

Oxbryta received approval last year for sickle cell disease management 

In 2019, the US government approved Global Blood’s Oxbryta to manage sickle cell disease in individuals aged 12 and over. The oral medication was approved in December 2021 to treat the illness in younger children. The drug’s sales increased by almost 50% to $194.7 million in 2021.

After a gloomy start to the calendar year, when a lack of significant purchases and clinical-stage treatment failures lowered investor morale and restricted funding, the biotech dealmaking pace has recently picked up again.

Also, Amgen Inc (NASDAQ: AMGN) also decided to purchase ChemoCentryx Inc on Thursday for $3.7 billion to obtain access to a possible breakthrough medication for inflammatory illnesses. AstraZeneca’s $39 billion acquisition of Alexion Pharmaceuticals in 2020 has put the realm of immune diseases in the limelight. The deal, which was announced before trading opened, will also give the corporation control of at least two investigational immune disorders medicines.

Please make sure to read and completely understand our disclaimer at While reading this article one must assume that we may be compensated for posting this content on our website.

The post Pfizer Inc (NYSE: PFE) To Acquire Global Blood Therapeutics For $5 Billion appeared first on Wall Street PR.

Read More

Continue Reading